Resultados de la búsqueda 321-330 of 3517 for Drug rehabilitation treatment
ABBV-383 is an investigational drug being ... care (SOC) chemotherapy regimens for the treatment of advanced colorectal carcinoma. ... The purpose of this study is ...
Mayo Clinic's high-tech pursuit of precision alcohol addiction treatment Aug. 29, 2024, 11:00 a.m. CDT. Productos y servicios. Boletín informativo: Mayo ...
Rochester, Minn. This study is designed to: -analyze effects of surgical treatment -improve surgical care and quality of life of patients with hip problems/ ...
... treatment. This study does not involve experimental treatment of any ocular tumor, but rather observation of tumor natural history or outcomes following ...
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers.
The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, ...
... treatment, first with spectacles alone, followed by patching (if ... treatment, and outcomes in the course of receiving currently available treatments.
The purpose of this study is to determine whether simultaneous treatment with spectacles and patching has an equivalent VA outcome compared with sequential ...
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?